106 related articles for article (PubMed ID: 30810967)
21. Allelic expression imbalance polymorphisms in susceptibility chromosome regions and the risk and survival of breast cancer.
Lin W; Lin HD; Guo XY; Lin Y; Su FX; Jia WH; Tang LY; Zheng W; Long JR; Ren ZF
Mol Carcinog; 2017 Jan; 56(1):300-311. PubMed ID: 27128794
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
23. MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability.
Ylikallio E; Woldegebriel R; Tumiati M; Isohanni P; Ryan MM; Stark Z; Walsh M; Sawyer SL; Bell KM; Oshlack A; Lockhart PJ; Shcherbii M; Estrada-Cuzcano A; Atkinson D; Hartley T; Tetreault M; Cuppen I; van der Pol WL; Candayan A; Battaloglu E; Parman Y; van Gassen KLI; van den Boogaard MH; Boycott KM; Kauppi L; Jordanova A; Lönnqvist T; Tyynismaa H
Brain; 2017 Aug; 140(8):2093-2103. PubMed ID: 28633435
[TBL] [Abstract][Full Text] [Related]
24. Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes.
Riaz M; Berns EM; Sieuwerts AM; Ruigrok-Ritstier K; de Weerd V; Groenewoud A; Uitterlinden AG; Look MP; Klijn JG; Sleijfer S; Foekens JA; Martens JW
Breast Cancer Res Treat; 2012 Jun; 133(3):843-51. PubMed ID: 21748294
[TBL] [Abstract][Full Text] [Related]
25. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
26. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.
Pooley KA; Baynes C; Driver KE; Tyrer J; Azzato EM; Pharoah PD; Easton DF; Ponder BA; Dunning AM
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3482-9. PubMed ID: 19064565
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
28. The critical role of germinal center-associated nuclear protein in cell biology, immunohematology, and hematolymphoid oncogenesis.
Sakai Y; Phimsen S; Okada S; Kuwahara K
Exp Hematol; 2020 Oct; 90():30-38. PubMed ID: 32827560
[TBL] [Abstract][Full Text] [Related]
29. Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.
Zhu RM; Lin W; Zhang W; Ren JT; Su Y; He JR; Lin Y; Su FX; Xie XM; Tang LY; Ren ZF
PLoS One; 2017; 12(6):e0178850. PubMed ID: 28591216
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer.
Hartikainen JM; Tengström M; Kosma VM; Kinnula VL; Mannermaa A; Soini Y
Cancer Res; 2012 Nov; 72(21):5537-46. PubMed ID: 22964583
[TBL] [Abstract][Full Text] [Related]
32. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
Chen Y; Shi C; Guo Q
World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
[TBL] [Abstract][Full Text] [Related]
33. Correlations of
Ma SJ; Liu YM; Zhang YL; Chen MW; Cao W
Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29089464
[TBL] [Abstract][Full Text] [Related]
34. Association of RETN and CAP1 SNPs, Expression and Serum Resistin Levels with Breast Cancer in Mexican Women.
Muñoz-Palomeque A; Guerrero-Ramirez MA; Rubio-Chavez LA; Rosales-Gomez RC; Lopez-Cardona MG; Barajas-Avila VH; Delgadillo-Barrera A; Canton-Romero JC; Montoya-Fuentes H; Garcia-Cobian TA; Gutierrez-Rubio SA
Genet Test Mol Biomarkers; 2018 Apr; 22(4):209-217. PubMed ID: 29641286
[TBL] [Abstract][Full Text] [Related]
35. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
[TBL] [Abstract][Full Text] [Related]
36. Pathway-Affecting Single Nucleotide Polymorphisms (SNPs) in RPS6KA1 and MBIP Genes are Associated with Breast Cancer Risk.
Shareefi G; Turkistani AN; Alsayyah A; Kussaibi H; Abdel Hadi M; Alkharsah KR
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2163-2168. PubMed ID: 32711446
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms of TP53-binding protein 1 (TP53BP1) gene and association with breast cancer risk.
Naidu R; Har YC; Taib NA
APMIS; 2011 Jul; 119(7):460-7. PubMed ID: 21635553
[TBL] [Abstract][Full Text] [Related]
38. Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
Azzato EM; Tyrer J; Fasching PA; Beckmann MW; Ekici AB; Schulz-Wendtland R; Bojesen SE; Nordestgaard BG; Flyger H; Milne RL; Arias JI; Menéndez P; Benítez J; Chang-Claude J; Hein R; Wang-Gohrke S; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kosma VM; Kataja V; ; Beesley J; Chen X; Chenevix-Trench G; Couch FJ; Olson JE; Fredericksen ZS; Wang X; Giles GG; Severi G; Baglietto L; Southey MC; Devilee P; Tollenaar RA; Seynaeve C; García-Closas M; Lissowska J; Sherman ME; Bolton KL; Hall P; Czene K; Cox A; Brock IW; Elliott GC; Reed MW; Greenberg D; Anton-Culver H; Ziogas A; Humphreys M; Easton DF; Caporaso NE; Pharoah PD
J Natl Cancer Inst; 2010 May; 102(9):650-62. PubMed ID: 20308648
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of caspase 8 -652 6N InsDel and Asp302His polymorphisms for breast cancer.
Kuhlmann JD; Bankfalvi A; Schmid KW; Callies R; Kimmig R; Wimberger P; Siffert W; Bachmann HS
BMC Cancer; 2016 Aug; 16():618. PubMed ID: 27507139
[TBL] [Abstract][Full Text] [Related]
40. Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancer risk and prognosis.
Ishitobi M; Miyoshi Y; Ando A; Hasegawa S; Egawa C; Tamaki Y; Monden M; Noguchi S
Clin Cancer Res; 2003 Apr; 9(4):1376-80. PubMed ID: 12684407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
